BerandaDIVISLAB • NSE
add
Divi's Laboratories Ltd
Tutup sebelumnya
₹6.804,00
Rentang hari
₹6.757,00 - ₹6.866,00
Rentang tahun
₹4.955,00 - ₹7.071,50
Kapitalisasi pasar
1,81 T INR
Volume Rata-Rata
446,45 rb
Rasio P/E
78,46
Hasil dividen
0,44%
Bursa utama
NSE
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 24,10 M | 13,79% |
Biaya operasional | 8,37 M | 13,26% |
Penghasilan bersih | 5,45 M | 26,74% |
Margin laba bersih | 22,61 | 11,38% |
Penghasilan per saham | 20,49 | 26,48% |
EBITDA | 7,16 M | 15,66% |
Tarif pajak efektif | 25,65% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 35,27 M | -4,62% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 149,69 M | — |
Saham yang beredar | 265,98 jt | — |
Harga terhadap nilai buku | 12,07 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 10,30% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 5,45 M | 26,74% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
Didirikan
12 Okt 1990
Situs
Karyawan
10.542
